The neurobiology of anorexia nervosa remains incompletely understood. Here we utilized PET imaging with the radiotracer [ 11 C]raclopride to measure striatal dopamine type 2 (D 2 ) receptor availability in patients with anorexia nervosa. 25 women with anorexia nervosa who were receiving treatment in an inpatient program participated, as well as 25 control subjects. Patients were scanned up to two times with the PET tracer [ 11 C]raclopride: once while underweight, and once upon weight restoration. Control subjects underwent one PET scan. In the primary analyses, there were no significant differences between underweight patients (n ¼21) and control subjects (n ¼ 25) in striatal D 2 receptor binding potential. Analysis of subregions (sensorimotor striatum, associative striatum, limbic striatum) did not reveal differences between groups. In patients completing both scans (n ¼15), there were no detectable changes in striatal D 2 receptor binding potential after weight restoration. In this sample, there were no differences in striatal D 2 receptor binding potential between patients with anorexia nervosa and control subjects. Weight restoration was not associated with a change in striatal D 2 receptor binding. These findings suggest that disturbances in reward processing in this disorder are not attributable to abnormal D 2 receptor characteristics, and that other reward-related neural targets may be of greater relevance.
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Introduction
The neurobiology of anorexia nervosa (AN) is incompletely understood. Current theories regarding the neurobiology of this illness are wide-ranging, and include hypotheses relevant to the possible placement of AN within the "internalizing" spectrum of disorders, including mood disorders, anxiety disorders, and obsessive compulsive disorder (OCD) (Forbush et al., 2010) , as well as hypotheses which suggest that brain reward systems may be altered in AN, thus altering motivation and responses towards food reward stimuli [reviewed in (Kaye et al., 2013) ]. As the striatal dopamine (DA) system bears potential relevance to both conceptualizations of this illness, the current study sought to assess brain reward circuitry in AN through evaluation of striatal dopamine D 2 receptor levels (specifically, D 2 receptor availability for tracer binding) using Positron Emission Tomography (PET) neuroimaging with the radiotracer [ 11 C]raclopride.
The striatal D 2 receptor is one of five dopamine (DA) receptor subtypes in the brain, with high concentration in the striatum. Within the striatum, the D 2 receptor acts as a presynaptic autoreceptor, regulating the release, re-uptake, and synthesis of DA; postsynaptically, it is also present on medium spiny neurons regulating outflow tracts from the striatum (Beaulieu and Gainetdinov, 2011; Ford, 2014) . The striatal D 2 receptor's role in reward processing has been considered in previous clinical studies. For example, studies of the striatal D 2 receptor in healthy human subjects have been performed using PET neuroreceptor neuroimaging with tracers such as [ 11 C]raclopride, which binds the D 2 family of receptors (including D 3 and D 4 receptors), indicating that striatal D 2 receptor availability (as measured by "binding potential") may influence preferences for rewards (Volkow et al., 1999; Volkow et al., 2002) . Whether such findings might relate to clinical expression of the extreme avoidance of food reward seen in AN is as yet unknown. Additionally, the striatal DA system, and specifically the D 2 receptor, is thought to influence cognitive flexibility, a neurobiological dimension thought to be impaired in disorders including OCD (Klanker et al., 2013) and AN (Tchanturia et al., 2014; Treasure and Schmidt, 2013 
